Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Noninvasive Tests of Atherosclerotic Burden : Writing Group III
about
Asymptomatic polyvascular abnormalities in community (APAC) study in China: objectives, design and baseline characteristics.Validity, intra- and inter-observer reliability of automated devices for the assessment of ankle brachial index using photo-plethysmography.Prediction of vascular risk after stroke - protocol and pilot data of the Prospective Cohort with Incident Stroke (PROSCIS).Asymptomatic cerebrovascular disease and systemic diagnosis in stroke, atherothrombosis as a disease of the vascular tree.Imaging of coronary atherosclerosis using computed tomography: current status and future directions.A new efficient trial design for assessing reliability of ankle-brachial index measures by three different observer groups.The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study, 1987-2001.Detection of aortic calcification during vertebral fracture assessment (VFA) compared to digital radiography.Profound influence of different methods for determination of the ankle brachial index on the prevalence estimate of peripheral arterial diseasePocket Doppler and vascular laboratory equipment yield comparable results for ankle brachial index measurement.Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study.Relationship between carotid intima-media thickness and coronary angiographic findings: a prospective studyPrevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA studyAlcohol consumption and ankle-to-brachial index: results from the Cardiovascular Risk Survey.Impressive predictive value of ankle-brachial index for very long-term outcomes in patients with cardiovascular disease: IMPACT-ABI study.Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients.New semiquantitative ultrasonographic score for peripheral arterial disease assessment and its association with cardiovascular risk factors.Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey--Applicability of the ankle-brachial-index measurement as screening device for high cardiovascular risk: an observational study.China suboptimal health cohort study: rationale, design and baseline characteristics.Current practice and future promise for clinical noninvasive measurements of subclinical atherosclerotic disease in the elderly.A review of electron beam computed tomography: implications for coronary artery disease screening.Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: a case-control study.Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis.Noninvasive Studies of Coronary and Peripheral Arterial Blood-flow.Childhood obesity and cardiovascular disease: links and prevention strategiesEffect of menopausal status on carotid intima-media thickness and presence of carotid plaque in Chinese women generation population.Surrogate measures of atherosclerosis and implications for evaluating cardiovascular risk.Agents that stabilise atherosclerotic plaque.Noninvasive atherosclerosis imaging for predicting cardiovascular events and assessing therapeutic interventions.Cardiovascular risk assessment in individual patients from carotid intimal-medial thickness measurements.Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitionersSubclinical cardiovascular disease in older adults: insights from the Cardiovascular Health Study.Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis.The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention.Noninvasive assessment of coronary atherosclerosis by multidetector-row computed tomography.Breast arterial calcifications as a cardiovascular risk marker in women.The validity of ankle-brachial index for the differential diagnosis of peripheral arterial disease and lumbar spinal stenosis in patients with atypical claudicationDistribution, size, and shape of abdominal aortic calcified deposits and their relationship to mortality in postmenopausal women
P2860
Q30444936-BE67F56D-CBA6-4E2A-B83B-BF32AA9C2D7BQ30446139-6514DDF8-BE79-43CB-9C30-9C6F6F52C7E8Q30559655-C8ADE881-883A-46E3-8538-D0588A091692Q31023308-E0D88B79-E26A-40F5-B829-0CFA98DEDFBBQ33201148-8C9CE6B3-9A73-49A8-BFEA-991E70AC97CDQ33252032-BC5BB6B7-9D49-4DE2-AB24-336DBF8AAA60Q33269431-7047799A-4D64-45B6-AA4B-1A7940F482DAQ33293528-BB85B41A-A5EB-4C2D-AC06-116EB0F7C970Q33320846-1A64919B-ADCC-483C-8006-2666044E8502Q33374409-4EC3E813-AA1F-4D38-81A8-D18D4B706BF4Q33516999-DA58B133-2B14-41E7-A857-C93891D35051Q33601376-0DA7EF86-89EC-47B8-9548-99EA89B02F0DQ33650331-A0D7780A-9B1D-48D4-AD37-7259D9DC09C7Q33769863-D8776098-9A39-4D28-910B-92AAF3E2C377Q33803200-6F266C89-7952-4586-B8E6-358843F313E9Q33888478-B97A497B-D32B-49C8-B9A5-7730FC3184CDQ33895487-3C9575E8-99AD-497C-BF15-33D8F439D13DQ34147477-EAB89E12-B0BC-4835-8096-27CC597094CAQ34356596-1288DB90-51CC-44A5-8FD1-21DB40CA48BCQ34542566-D4425F7E-2C3C-429F-AF4D-096892D3F892Q34548836-335BE038-3690-47E7-891D-7368F39BDF4DQ34622140-38210A99-5877-43CE-BE40-279519F99CFDQ34637543-F9C3E783-0CAF-41AA-88A8-D3444BF127D4Q34680467-F14DA5B9-4CAF-4D13-87BA-843A71111F3EQ34760603-8428234C-D6EE-4B76-8864-3BDDABA438FAQ34774230-74E2A664-DA0E-4B85-A3BF-F5F5DD0C52CAQ34939164-9E948F66-66B7-4CFD-992A-834048835F02Q35020549-EDB4BF48-5FB8-4943-8F83-D9C95AC901D3Q35083561-C063C640-8EEC-48B5-A9A8-206686448452Q35547296-425DA535-205F-43FA-96F0-2110D2A980E5Q35602766-77A4FC84-8EC6-4F10-A5DE-AE1316001A84Q35739809-4C341EC4-EA12-48C7-BB29-6C29B28AB45BQ35753098-BE9FE666-5A1A-43A2-B728-F8FC9A53598DQ35767519-41D94D2A-B6E6-4279-BF67-52EE54F7BFCDQ35824614-E5F43C19-A1E7-4793-9660-279783154777Q35827593-B833D4A2-2B75-47EB-9498-2626AD469B69Q35879085-EECCC244-AB71-4316-98F4-C098171DF627Q35879099-34DC10CA-6AA3-4EA0-BAC4-BA8FC02DAC9FQ36004368-3840DC10-41B2-4C66-B78B-4548385C2287Q36032014-F18DD949-3BCA-48A0-9B02-ADF6D50139D3
P2860
Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Noninvasive Tests of Atherosclerotic Burden : Writing Group III
description
article
@en
im Januar 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2000
@uk
ലേഖനം
@ml
name
Prevention Conference V : Beyo ...... tic Burden : Writing Group III
@en
Prevention Conference V : Beyo ...... tic Burden : Writing Group III
@nl
type
label
Prevention Conference V : Beyo ...... tic Burden : Writing Group III
@en
Prevention Conference V : Beyo ...... tic Burden : Writing Group III
@nl
prefLabel
Prevention Conference V : Beyo ...... tic Burden : Writing Group III
@en
Prevention Conference V : Beyo ...... tic Burden : Writing Group III
@nl
P2093
P356
P1433
P1476
Prevention Conference V: Beyon ...... otic burden: Writing Group III
@en
P2093
Aurigemma GP
Crouse JR 3rd
Friedman L
Greenland P
Herrington DM
P304
P356
10.1161/01.CIR.101.1.E16
P407
P577
2000-01-01T00:00:00Z